Aeroallergy results from maladaptive immune responses to ubiquitous, otherwise innocuous environmental proteins 1 . Although the proteins targeted by aeroallergic responses represent a tiny fraction of the airborne proteins humans are exposed to, allergenicity is a quite public phenomenon-the same proteins typically behave as aeroallergens across the human population. Why particular proteins tend to act as allergens in susceptible hosts is a fundamental mechanistic question that remains largely unanswered. The main house-dust-mite allergen, Der p 2, has structural homology with MD-2 (also known as LY96), the lipopolysaccharide (LPS)-binding component of the Toll-like receptor (TLR) 4 signalling complex [2] [3] [4] . Here we show that Der p 2 also has functional homology, facilitating signalling through direct interactions with the TLR4 complex, and reconstituting LPS-driven TLR4 signalling in the absence of MD-2. Mirroring this, airway sensitization and challenge with Der p 2 led to experimental allergic asthma in wild type and MD-2-deficient, but not TLR4-deficient, mice. Our results indicate that Der p 2 tends to be targeted by adaptive immune responses because of its autoadjuvant properties. The fact that other members of the MD-2-like lipid-binding family are allergens, and that most defined major allergens are thought to be lipid-binding proteins 5 , suggests that intrinsic adjuvant activity by such proteins and their accompanying lipid cargo may have some generality as a mechanism underlying the phenomenon of allergenicity.
Although the potential biological significance of several allergens having protease activity has received experimental attention 5, 6 , cogent mechanistic hypotheses for why most aeroallergens have a propensity to generate maladaptive effector T-cell responses are lacking. TLRs, receptors for conserved microbial structures, have a critical role in the controlling initiation and class specification of adaptive immune responses by antigen-presenting cells (APCs) 7 . Exogenous antigen presentation by APCs in the absence of direct TLR stimulation generally leads to tolerance 8 . Moreover, efficient generation of effector T-cell responses by APCs is dependent on the presence of TLR ligands in the phagosome containing the antigen being presented 9 .
House dust mites are a major source of aeroallergens for patients with allergic asthma 10 . Concentrated in mite faecal pellets 11 , the major group 2 allergens, Der p 2 and Der f 2, are highly allergenic; among defined dust mite antigens, they have the highest rates of skin test positivity in atopic patients 12 . Sequence homology places these allergens in the recently recognized MD-2-related lipid-recognition domain family of proteins 13 . Notably, the crystal structures of MD-2 and Der p 2 exhibit structural homology [2] [3] [4] , as previously predicted 14 , with two anti-parallel b-pleated sheets stabilized by disulphide bonds and enclosing a hydrophobic cavity accessible from one end. Several lines of evidence have linked exposure to LPS with regulation of the development of allergic asthma, as well as with exacerbation of existing asthma 15 .
These considerations suggested that there may also be functional homology between MD-2 and Der p 2. We examined the effect of Der p 2 on TLR4 signalling in HEK293 cells, which lack endogenous TLR4 and MD-2 but have fully functional TLR signalling machinery. Der p 2 reconstituted LPS-driven TLR4 signalling and interleukin (IL)-8 production in HEK293 cells in the absence of MD-2 ( Fig. 1a ). Furthermore, Der p 2 augmented LPS-driven IL-8 production in HEK293 cells co-expressing TLR4 and MD-2 ( Fig. 1b) . Notably, LPSdriven TLR4 signalling was more robust in the presence of MD-2 alone in comparison to Der p 2 alone. The effects of Der p 2 on HEK293 cell production of IL-8 were TLR4-and LPS-dependent (data not shown). In contrast, Der p 2 did not increase IL-1-driven IL-8 production ( Fig. 1b ), suggesting specific effects of Der p 2 on TLR4 activation and not on the signalling pathways shared with the IL-1 receptor. RP105-MD-1, a cell surface heterodimer structurally related to TLR4-MD-2, inhibits TLR4 signalling in myeloid and HEK293 cells; the interaction of RP105-MD-1 with TLR4-MD-2 reduces the ability of the latter complex to bind LPS 16 . Der p 2 blunted the decrease in LPS-driven IL-8 production observed in HEK293 cells expressing RP105-MD-1 as well as TLR4-MD-2 ( Supplementary Fig. 1 ).
All sequenced MD-2 species contain a conserved tyrosine (Tyr 102) at a site functionally important for TLR4 signaling 4, 17 ( Supplementary Fig. 2 ). This tyrosine, which resides in a loop formed between cysteines of a disulphide bridge (Cys 95-Cys 105 in MD-2; Cys 89-Cys 94 in Der p 2), is absent in MD-1 but conserved in Der p 2 (Tyr 91). Mutation of this tyrosine to alanine (Y91A) ablated the ability of Der p 2 to reconstitute LPS-driven IL-8 production in HEK293 cells expressing TLR4 without MD-2 ( Fig. 1c ), or to augment LPS-driven IL-8 production in HEK293 cells co-expressing TLR4 and MD-2 ( Fig. 1d ). Thus, in HEK293 cells, Der p 2 promotes LPS-induced TLR4 signalling in a manner that appears to depend on Der p 2 and TLR4 interactions.
The direct association of Der p 2 with TLR4 was demonstrated by co-immunoprecipitation in lysates of cells co-expressing epitopetagged Der p 2-TLR4 ( Fig. 2a ). Interaction of Der p 2 with the ectodomain of TLR4 (TLR4 ECD ) was shown by co-capture of Der p 2 by protein G beads after incubation of Der p 2 with a TLR4 ECD -F c fusion protein ( Supplementary Fig. 3 ). Like MD-2, recombinant Der p 2 (rDer p 2) forms disulphide-linked aggregates ( Supplementary Fig.  4 ). In a further parallel with MD-2, it is the monomeric form of Der p 2 that co-immunoprecipitates with TLR4 and with MD-2 (data not shown). Direct association of Der p 2-HA and MD-2-Flag was shown by co-immunoprecipitation in cell lysates using antibodies to haemagglutinin (HA) and Flag (Fig. 2b ). Like MD-2, Der p 2 also associated with CD14 ( Fig. 2c ). Of interest, whereas immunoprecipitation analysis of Der p 2(Y91A) suggested that this non-functional mutant interacts with TLR4 and MD-2 in a manner similar to that of native Der p 2 (data not shown), Der p 2(Y91A) exhibited increased binding to CD14 in such assays ( Supplementary Fig. 5 ). The ability of Der p 2(Y91A) to bind TLR4 is consistent with crystallographic data that does not show any direct involvement of MD-2 Tyr 102 in the TLR4 interaction 4 . The observed increased affinity of Der p 2(Y91A) for CD14 suggests that this mutation may interfere with TLR4 signalling by altering the dynamics of CD14 engagement and/or LPS transfer. Notably, the co-expression of Der p 2 with MD-2 and TLR4 increased the co-immunoprecipitation of TLR4 with MD-2 ( Fig. 2d) ; this suggests that interactions between the heterodimers TLR4-MD-2 and TLR4-Der p 2 could contribute to the increased TLR4-dependent activation by LPS observed when cells co-expressing TLR4 and MD-2 also express Der p 2 (Fig. 1b, d) . Similarly, Der p 2 reduced the co-immunoprecipitation of MD-2 with MD-1 ( Supplementary Fig.  6 ), suggesting that the inhibition of interactions between RP105-MD-1 and MD-2-TLR4 by Der p 2 contributes to the increased activation by LPS of cells co-expressing TLR4-MD-2 and RP105-MD-1 when Der p 2 is present ( Supplementary Fig. 1 ). Furthermore, like MD-2 (but not MD-1) 16 , Der p 2 binds LPS, as demonstrated by co-precipitation of Der p 2-HA with biotinylated LPS captured by streptavidin beads (Fig. 2e ). Thus, Der p 2 can bind TLR4, MD-2, CD14 and LPS. Taken together, these data suggest that Der p 2 facilitates the aggregation of TLR4 needed for receptor activation by promoting interactions between TLR4-MD-2 and Der p 2-TLR4 in the presence of MD-2, and between TLR4-Der p 2 and Der p 2-TLR4 in the absence of MD-2.
To model the interactions of exogenously delivered Der p 2 with host cells important in inducing adaptive immune responses, we tested the effect of Der p 2 on primary APCs. Der p 2, immunoaffinitypurified from house dust mites, induced TNF-a secretion by mouse bone-marrow-derived dendritic cells ( Supplementary Fig. 7) . Like LPS-induced signalling in these cells, Der p 2-triggered activation was TLR4-dependent ( Supplementary Fig. 7b ) but not TLR2dependent ( Supplementary Fig. 7d ). In contrast to LPS, Der p 2 could also activate dendritic cells from MD-2-null mice ( Supplementary  Fig. 7c ), mimicking the TLR4-activating properties of LPS-MD-2 complexes 18, 19 . The immunoaffinity-purified Der p 2 was indeed contaminated with endotoxin-like activity (equivalent to 0.4 ng Escherichia coli LPS per mg Der p 2), suggesting that the observed TLR4-dependent activation of dendritic cells by Der p 2 was mediated by endotoxin-Der p 2 complexes. To test this more directly, we generated recombinant Der p 2 in a baculovirus expression system. At physiological temperatures, MD-2 secreted into serum-free media rapidly loses biological activity in the absence of LPS 18 . Similarly, rDer p 2 secreted in the absence of LPS was inactive in functional assays (data not shown). Thus, we generated and purified rDer p 2 in the presence of defined amounts of E. coli LPS. rDer p 2 recovered under these conditions stimulated TLR4dependent production of TNF-a, IL-12/23p40 and IL-6 by mouse peritoneal macrophages, in the presence and absence of MD-2 ( Supplementary Fig. 8 ). The amount of LPS co-purified with Der p 2 (60 pg LPS per 100 mg Der p 2) was sub-stoichiometric, and insufficient to activate the macrophages in the absence of Der p 2 ( Supplementary Fig. 8a, c) . Thus, exogenously delivered Der p 2 facilitates LPS signalling in primary APCs, with or without MD-2.
Taken together, these data suggest that the propensity of Der p 2 to be a target of adaptive immune responses is due to the fact that Der p 2 promotes TLR4 signalling and thus has auto-adjuvant activity. This also suggested a mechanism for allergenicity. High levels of exposure to bacterial products such as LPS in early life are inversely correlated with the development of atopy and allergic disease [20] [21] [22] . Usually interpreted in the context of the hygiene hypothesis, it is thought that such exposures lead to the development of robust counter-regulatory responses 23 . However, epidemiological and human challenge data indicate that LPS exposure can exacerbate established asthma, probably by stimulating pro-inflammatory responses in the airway 20, 24 .
In addition to confirming the ability of LPS to intensify established asthma 25 , mouse models have provided mechanistic insight into the role of LPS in regulating the development of allergic asthma. Consonant with the hygiene hypothesis, an important variable appears to be the LPS dose. Whereas airway sensitization with a model antigen (ovalbumin; OVA) along with very low-dose (,1 ng) LPS induces tolerance, airway sensitization with OVA along with low-dose (100 ng) LPS drives T H 2 immune responses and allergic asthma in a TLR4-dependent fashion 26 . Conversely, airway sensitization with OVA along with high-dose (100 mg) LPS drives a T H 1 response, probably along with a robust regulatory response as well 26, 27 .
We tested the ability of Der p 2 to induce experimental allergic asthma. Sensitization and challenge with Der p 2, along with extremely low-dose (low pg range) LPS, induced robust airway T H 2 inflammation-marked by airway eosinophilia and lymphocytosis, mucous metaplasia and increased plasma IgE concentrations-in wild type but not TLR4-deficient mice (Fig. 3) . Notably, Der p 2 similarly induced T H 2 inflammation in the airways of MD-2-deficient mice (Fig. 4) . On the other hand, mutant Der p 2(Y91A) failed to induce experimental allergic asthma ( Supplementary Fig. 9 ). Thus, in vivo allergenic activity mirrors in vitro functional and biochemical activity: Der p 2 efficiently drives airway T H 2 inflammation in vivo in a TLR4dependent manner, and retains the ability to drive such inflammation in the absence of MD-2.
Der p 2-mediated facilitation of TLR4 signalling under conditions of very low ambient LPS exposure, those associated with increasing rates of atopy and aeroallergy, may thus shift the LPS-response curve into the T H 2-inducing range. Similarly, Der p 2 probably promotes LPSdriven exacerbation of established asthma by facilitating TLR4 signalling by airway cells. Here, the ability of Der p 2 to reconstitute TLR4 signalling in the absence of MD-2 may well be of special importance as airway epithelial cells express TLR4, but little or no MD-2 (ref. 28) .
Although the interaction of Der p 2 with vertebrate TLR4-MD-2 is unlikely to be of biological importance to the mite, it is tempting to speculate that Der p 2 has a physiological role in the innate immune system of the dust mite gut. The pathophysiological interactions of Der p 2 with the vertebrate immune system may be more than a unique oddity. Other MD-2-related lipid-recognition domain family members are aeroallergens 13 . More generally, more than 50% of defined major allergens are lipid-binding proteins 5 . Intrinsic adjuvant activity provided by associated lipids may well underlie the allergenicity of such proteins.
METHODS SUMMARY
Generation of recombinant Der p 2. Recombinant His-tagged Der p 2 (rDer p 2) was generated in baculovirus systems using the pAcGP67A transfer vector (BD Pharmingen) and Sf21 cells, and purification with Ni-NTA agarose beads (Qiagen). rDer p 2 was generated under FCS-free conditions (Baculogold Max-XP media, BD Pharmingen), in the presence of E. coli LPS (100 ng ml 21 ) and LPS-free human serum albumin (HSA; 0.25%) as a carrier and for stability 29 .
In vitro cell stimulation. HEK293 cell stimulation and analysis was as described 16 . Bone-marrow-derived dendritic cells and thioglycollate-elicited LETTERS peritoneal macrophages were generated as described 16 from wild type, Md-2 2/2 (K. Miyake), Tlr2 2/2 and Tlr4 2/2 mice (S. Akira)-all on a C57BL/ 6 background (.10 generations). Twenty-four hours after stimulation (or mock-stimulation), cell-free supernatants were collected and cytokine production was quantified by ELISA (BD Pharmingen). Experimental allergic asthma model. Ten-twelve-week-old female wild type, Md-2 2/2 and Tlr4 2/2 mice were sensitized and challenged according to the protocol previously described 26 , with minor modifications. In brief, mice anaesthetized with ketamine-xylazine were sensitized intranasally on days 0, 1 and 2 with either rDer p 2 (0.1 mg) in PBS (co-purified with E. coli LPS (0.026 pg) and HSA (0.3 ng)), or with PBS (with E. coli LPS (0.026 pg) and HSA (0.3 ng)). Mice were subsequently challenged intranasally with 1/4 of the sensitization dose on days 14, 15, 18 and 19. For experiments with Md-2 2/2 mice, sensitization and challenge doses of Der p 2-LPS were 10-fold higher. On day 21, mice were killed and airway inflammation, serum IgE concentrations and airway mucus metaplasia were assessed as previously described 30 . Animal care was provided in accordance with National Institutes of Health guidelines in studies approved by the CCHMC IACUC.
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